LBO — HOUSTON NORTHWEST MEDICAL CENTER
IRR: 22.3% | MOIC: 2.74x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
22.3%
IRR
2.74x
MOIC
$174.7M
Entry EV
$326.2M
Exit EV
$89.9M
Equity Invested
Sources & Uses
S&UTotal · $174.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $67.8M | 38.8% | |
| Sub Debt | $17.0M | 9.7% | |
| Equity | $89.9M | 51.5% | |
| Enterprise Value | $169.6M | 97.1% | |
| Transaction Fees | $5.1M | 2.9% | |
| Total Uses | $174.7M | 100.0% |
Interpretation
INTAt 2.74x MOIC and 22.3% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $31.1M |
| Exit Ev | $326.2M |
| Net Debt At Exit | $80.1M |
| Equity At Exit | $246.1M |
| Equity Invested | $89.9M |
| Total Value Created | $156.3M |
| Value From Growth | $148.2M |
| Value From Multiple | $8.5M |
| Value From Deleveraging | $4.7M |